Healthcare -
Biotechnology - NASDAQ - US
$ 7.9
0.381 %
$ 1.64 B
Market Cap
-12.95
P/E
BCRX - LONG-TERM DEBT
Long-term Debt BCRX - BioCryst Pharmaceuticals, Inc.
822 M
LAST VALUE
17.93%
2 YEAR CAGR
96.50%
5 YEAR CAGR
39.25%
10 YEAR CAGR